And the seafood industry and failed schools for minority students. This is about one hour and 40 minutes. Good morning, everyone. Im tom patterson, the interim director of the shorenstein center. This is the followup to last evenings Goldsmith Awards Program. Event this part of the where we have a finalist for the goldsmith investigative reporting award take us a little bit behind the story. How they came to it. Some of the difficulties they faced, and then we can all have a conversation about these stories and investigative reporting generally. I would like to thank the Greenfield Foundation which underwrites the goldsmith awards. They have supported it through its 24 years unveiling way unfailing. It would not be the type of program it is without that marvelous family. What i am going to do, i will introduce you to the panelist. I think i will do them one at a time when you are up, rather than going down the line. By the time they come up, you sometimes forget which one they were. So
Says shied saved her life at the bus stop earlier this month. She grabbed me a couple weeks ago to get me out of the way of cars. I was than the there for her today report report driver is an 18 yearold High School Student at a technical school, police say he drove past the buses stop sign arm and hit zeka as she crossed the street were four other students. When didnt see it or disregarded it, i dont know, investigation is on going. Reporter grief counselors were at the the high school where zeka was a sophomore and technical the driver attend. There are no crossing guards for students but School Officials will see if that policy should be modified and if other changes are needed. Some of the things that were looking at here is increasing bus routes, changing bus locations. Reporter School Officials say it is up to the Police Department to deciding whether or not High School Students need cross willing guards. Now School Officials and police will meet tomorrow afternoon, to discuss som
This is a hearing about the pat, Patient Involvement in fda drug approvals, and i think we can agree they deserve a seat at the table. When companies are developing drugs and medical devices within the Clinical Trial process. I have long been a supporter of the department of defenses congressionallydirected medical Research Program known as the cdmrp. It funds peerreviewed research into Breast Cancer, autism, ovarian cancer, Prostate Cancer and other diseases. And since 1993 the patients have been involved and have been attar of cdmrp, and they have a consumer reviewer as part of the peerreviewed possible to represent the stakeholder community. And its been very successful in combining Patient Perspectives and needs with Scientific Research and bringing those perspectives together. Has fda, as you begin to consider improving Patient Involvement, have you looked at cdrmp to see if theres anything you can borrow from that in the drug approval process . Uhhuh. We have not, and thats a goo
Trials because they are being treated in places that are not running trials. We need to move this out in to the community, make those folks eligible. And im on the committee in the lung map trial, and i have really urged that we make sure that we are out there in the community so that anyone who has lung cancer has an opportunity to participate in the research and perhaps, have a more effective therapy. So, i think the Electronic Health records that its a huge different area that we are working on and how to do Clinical Trials utilizing the infrastructure that is emerging. Right, thank you very much. Chair, thanks, gentle lady, and now recognize gentleman from new jersey. Five minutes. Thank you very much, mr. Chairman. A focus of your testimony has been focused on fdas efforts on Patient Engagement. Its my understanding that clinicaltrials. Gov was intended to provide Clinical Study information for patients, Health Care Providers and researchers. But it seems to me that this site lack
And im on the committee in the lung map trial, and i have really urged that we make sure that we are out there in the community so that anyone who has lung cancer has an opportunity to participate in the research and perhaps, have a more effective therapy. So, i think the Electronic Health records that its a huge different area that we are working on and how to do Clinical Trials utilizing the infrastructure that is emerging. Right, thank you very much. Chair, thanks, gentle lady, and now recognize gentleman from new jersey. Five minutes. Thank you very much, mr. Chairman. A focus of your testimony has been focused on fdas efforts on Patient Engagement. Its my understanding that clinicaltrials. Gov was intended to provide Clinical Study information for patients, Health Care Providers and researchers. But it seems to me that this site lacks considerable information and has proven to be difficult to navigate. Dr. Woodcock, would you please comment on the current utility of clinicaltrials